About Me
Jalal Ahmed Khan, MD, PhD, is a radiation oncologist in the Department of Radiation Oncology and a physician scientist with a laboratory in the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai (ISMMS). Jalal is also a member of the Icahn Genomics Institute. Jalal studied biomedical engineering at Columbia University and then immunology and developmental biology as part of the combined MD/PhD training program at ISMMS. He completed his graduate work with Paul Frenette and Miriam Merad studying the expansion of hematopoietic stem cells. He completed his internship in internal medicine at Northwell Health and the ABR Holman Research Pathway residency program in radiation oncology at the ISMMS. During residency, he conducted research with Miriam Merad and Michel Sadelain to modulate the tumor immune microenvironment with radiotherapy to improve the anti-tumor activity of chimeric antigen receptor (CAR) T cells.
The lab aims to design novel CAR T cell therapies informed by the study of myeloid cells that play a key role in shaping the composition of the tumor microenvironment and the response to cancer immunotherapy.
Language
Position
ASSISTANT PROFESSOR | Radiation OncologyHospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Queens
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai West
About Me
Jalal Ahmed Khan, MD, PhD, is a radiation oncologist in the Department of Radiation Oncology and a physician scientist with a laboratory in the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai (ISMMS). Jalal is also a member of the Icahn Genomics Institute. Jalal studied biomedical engineering at Columbia University and then immunology and developmental biology as part of the combined MD/PhD training program at ISMMS. He completed his graduate work with Paul Frenette and Miriam Merad studying the expansion of hematopoietic stem cells. He completed his internship in internal medicine at Northwell Health and the ABR Holman Research Pathway residency program in radiation oncology at the ISMMS. During residency, he conducted research with Miriam Merad and Michel Sadelain to modulate the tumor immune microenvironment with radiotherapy to improve the anti-tumor activity of chimeric antigen receptor (CAR) T cells.
The lab aims to design novel CAR T cell therapies informed by the study of myeloid cells that play a key role in shaping the composition of the tumor microenvironment and the response to cancer immunotherapy.
Language
Position
ASSISTANT PROFESSOR | Radiation OncologyHospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Queens
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai West
About Me
Jalal Ahmed Khan, MD, PhD, is a radiation oncologist in the Department of Radiation Oncology and a physician scientist with a laboratory in the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai (ISMMS). Jalal is also a member of the Icahn Genomics Institute. Jalal studied biomedical engineering at Columbia University and then immunology and developmental biology as part of the combined MD/PhD training program at ISMMS. He completed his graduate work with Paul Frenette and Miriam Merad studying the expansion of hematopoietic stem cells. He completed his internship in internal medicine at Northwell Health and the ABR Holman Research Pathway residency program in radiation oncology at the ISMMS. During residency, he conducted research with Miriam Merad and Michel Sadelain to modulate the tumor immune microenvironment with radiotherapy to improve the anti-tumor activity of chimeric antigen receptor (CAR) T cells.
The lab aims to design novel CAR T cell therapies informed by the study of myeloid cells that play a key role in shaping the composition of the tumor microenvironment and the response to cancer immunotherapy.
Language
Position
ASSISTANT PROFESSOR | Radiation OncologyHospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Queens
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai West
Education
MD, Icahn School of Medicine at Mount Sinai
Internship, Internal Medicine
Hofstra North Shore-Lij School Of Medicine
Residency, Radiation Oncology
Icahn School Of Medicine At Mount Sinai
Certifications
Radiation Oncology
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Ahmed did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Doctors